No Image

Industry Information and Guidance

September 29, 2022 AutoBot 0

FDA review of biosimilar and interchangeable products requires a 351(k) biologics license application that includes information demonstrating biosimilarity.

No Image

An Alternative to Ozone

September 29, 2022 AutoBot 0

I’ve been an organic chemist for decades now, but I have somehow never had the need to run an ozonolysis reaction. It’s a specialized operation, […]

No Image

Amazon seeks physician lead

September 29, 2022 AutoBot 0

Amazon Web Services is seeking a San Francisco-based physician lead to work with healthcare organization leaders and strategic industry partners, attend industry events and forums, […]

No Image

In re Cellect*

September 29, 2022 AutoBot 0

By Kevin E. Noonan — The Federal Circuit soon will have the opportunity to decide a question left open during a recent spate of opinions […]